SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-046225
Filing Date
2013-08-23
Accepted
2013-08-23 09:01:12
Documents
1
Period of Report
2013-08-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd388999.html 4  
1 FORM 4 rrd388999.xml 4 3454
  Complete submission text file 0001181431-13-046225.txt   5086
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10307 PACIFIC CENTER COURT SAN DIEGO CA 92121
Business Address
CHASE ANTHONY R (Reporting) CIK: 0001223756 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14895 | Film No.: 131056298